HomeInsightsResults

Natco Pharma Ltd Quarterly Result

Natco Pharma Ltd Quarterly Result

stocks purchased

₹ 2.9 Cr

Volume transacted

stocks purchased

21.4 K

stocks traded

Last Updated time: 29 Oct 9.00 AM

Results Analysis

Revenue

1,362 Cr

stock direction

294 (27.53%)

1,068 Cr

NetProfit

668 Cr

stock direction

282 (73.06%)

386 Cr

EBIDTA

804 Cr

stock direction

307 (61.77%)

497 Cr

Key Highlights

  • The Market Cap of Natco Pharma Ltd changed from ₹ 10515 crore on March 2019 to ₹ 17042 crore on March 2024 . This represents a CAGR of 8.38% over 6 years. .
  • The Revenue of Natco Pharma Ltd changed from ₹ 918.9 crore to ₹ 1410 crore over 9 quarters. This represents a CAGR of 20.99% .
  • The EBITDA of Natco Pharma Ltd changed from ₹ 429.6 crore to ₹ 852.9 crore over 9 quarters. This represents a CAGR of 35.63% .
  • The Net Pr of Natco Pharma Ltd changed from ₹ 320.4 crore to ₹ 668.5 crore over 9 quarters. This represents a CAGR of 38.66% .

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
29 Oct 20241341.1
28 Oct 20241322.4
25 Oct 20241292.3
24 Oct 20241339.1
23 Oct 20241318
22 Oct 20241328.15
21 Oct 20241370.9
18 Oct 20241398.6
17 Oct 20241389.35
16 Oct 20241398.85

Historical Market Cap of Natco Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Natco Pharma Ltd News Hub

News

Natco Pharma to announce Quarterly Result

Natco Pharma will hold a meeting of the Board of Directors of the Company on 12 November 2...

Read more

29 Oct 202414:02

News

Natco Pharma Ltd rises for third straight session

Natco Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1460...

Read more

09 Oct 202413:05

News

Natco Pharma soars after Mylan settles Ozempic patent dispute

Natco Pharma announced that its partner, Mylan Pharmaceuticals Inc., reached a settlement ...

Read more

07 Oct 202415:28

News

Natco Pharma Ltd slips for fifth straight session

Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 15...

Read more

19 Sep 202413:35

News

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) In...

Read more

04 Sep 202412:07

News

Natco Pharma Canada arm invests $8 mln in eGenesis

eGenesis is engaged in using its multiplex gene editing and genome engineering platform to...

Read more

04 Sep 202412:01

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

FAQs for Quarterly Results of Natco Pharma Ltd

What key financial metrics are included in Natco Pharma Ltd's quarterly results?

Key financial metrics in Natco Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Natco Pharma Ltd announce its quarterly results?

Natco Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Natco Pharma Ltd's quarterly performance impact its stock price?

Natco Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Natco Pharma Ltd's quarterly results on dividends?

The impact of Natco Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Natco Pharma Ltd's quarterly results?

Yes, Natco Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*